Amid the worst season of the former first-rounder’s career, Abel worked to “understand better who I am as a person and a ...

Individual investors have become the most bearish since 2023, while risk appetite is rising among institutional fund managers ...

H.C. Wainwright analyst Douglas Tsao lowered the firm’s price target on Outlook Therapeutics (OTLK) to $3 from $30 and keeps a Buy rating on ...

While the Dodgers, Mets, and Diamondbacks got significantly better, it shouldn’t overshadow the Phillies' potential.

Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved ...